SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

CyberArk founder: "The process of building a high-tech company is full of endless failures"

Deloitte Launchpad announces 5th cohort with 10 new startups

Major TAU benefactor to consider halting investments over judicial reform

Minute Media eyeing more acquisitions, becoming profitable, says CEO

Buzz

Most popular

Daily

Weekly

1

Deloitte Launchpad announces 5th cohort with 10 new startups

2

Creator investment platform Exceed raises $8 million Seed round

3

"Investments in Israel have all but disappeared - also because of the judicial coup”

4

The 50 most promising Israeli startups - 2022

5

daily.dev raises $11 million in Seed funding to build a professional network for developers

Multiple Sclerosis

2 stories about Multiple Sclerosis

ה מטה הנוכחי של טבע ב ארה"ב

Mylan Cuts Price of Generic Copaxone Offering by 60%

11.07.18|Lilach Baumer

Mylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800

Former Teva Executive One Step Closer to Bringing Copaxone Rival to Market

31.10.17|Lilach Baumer

Mapi Pharma announced a successful phase II clinical trial for its Copaxone equivalent GA Depot